Mechanism of APTX nicked DNA sensing and pleiotropic inactivation in neurodegenerative disease
Percy Tumbale(National Institute of Environmental Health Sciences), R. Scott Williams(University of North Carolina at Chapel Hill), Matthew J. Schellenberg(Mayo Clinic), Mandy Watson(University of Manchester), Ian D. Waddell(Charles River Laboratories (United Kingdom)), Emma Fairweather(University of Manchester), J.M. Krahn(National Institutes of Health), Robert E. London(National Institute of Environmental Health Sciences), Geoffrey A. Mueller(National Institutes of Health), Jessica Neville Little(University of Virginia)
Cited by 20
Related Papers
Deficiency of terminal ADP‐ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease
|The EMBO Journal|2013|309
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia
|Nature Cancer|2021|279
Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1
|Nature Structural & Molecular Biology|2004|231